BT-474 cells are positive for all three receptors, MCF7 cells ER+, PR+ and HER2− and MDA-MB-231 cells classified as triple-negative breast cancer (ER−, PR−, HER2−) (reviewed in [24]). This evidence concerns the gene PGR and triple-negative breast carcinoma.